Brazil Pharma has a national footprint, with over half of its stores located outside the Southeast region. It has achieved strong growth through new store openings and acquisitions since its IPO, while also improving productivity and efficiency.
Illicit liquor trade poses a serious threat to government, socially
as well economically. Excise duty which is an important source
of revenue is continually under threat from the practice of illicit
trade. Considerable amount of money which could be used to
benefit the government services of a country are being diverted
to the pockets of criminals participating in illegal trading. In
addition, the illicit trade in liquor poses a serious threat to
consumer health.
To counteract it, some State governments have implemented
Tax Stamps as part of their anti-counterfeiting strategy. This
has not only minimized the hooch tragedies and duplication but
has also substantially increased the excise revenue collection in
States.
This issue brings our cover story on “TAX STAMPS
ROLE IN IMPLEMENTING IDEAL STATE EXCISE
POLICY”. Apart from this, the issue also covers interviews,
industry updates & news.
We hope you will find this issue informative and interesting and
as always, we look forward to receiving your feedback.
If you have any news, contributions or comments for the
editorial team, please feel free to email us at info@aspaglobal.
com
Illicit liquor trade poses a serious threat to government, socially
as well economically. Excise duty which is an important source
of revenue is continually under threat from the practice of illicit
trade. Considerable amount of money which could be used to
benefit the government services of a country are being diverted
to the pockets of criminals participating in illegal trading. In
addition, the illicit trade in liquor poses a serious threat to
consumer health.
To counteract it, some State governments have implemented
Tax Stamps as part of their anti-counterfeiting strategy. This
has not only minimized the hooch tragedies and duplication but
has also substantially increased the excise revenue collection in
States.
This issue brings our cover story on “TAX STAMPS
ROLE IN IMPLEMENTING IDEAL STATE EXCISE
POLICY”. Apart from this, the issue also covers interviews,
industry updates & news.
We hope you will find this issue informative and interesting and
as always, we look forward to receiving your feedback.
If you have any news, contributions or comments for the
editorial team, please feel free to email us at info@aspaglobal.
com
The Irrationality of Measuring Brand Performance: Using Fame, Feeling & Fluen...System1 Group
Learning from behavioural science has taught us that humans think a lot less than we think they think. It demands the abandonment of the classical cognitive and persuasion-based marketing and communication models and instead, favors a simple, straightforward System 1 inspired brand-building approach governed by Fame, Feeling & Fluency:
•Fame: If a brand comes readily to mind, it's a good choice.
•Feeling: If a brand feels good, it's a good choice.
•Fluency: If a brand is recognizable, it's a good choice.
Tune in to hear Gabriel Aleixo (Managing Director - LatAm) and Alex Haubold (Research Associate) highlight how Coca-Cola deployed the highly predictive brand tracking model in Brazil to engage consumers in real time during the Rio 2016 Olympic Games. It will bring to life how Fame, Feeling & Fluency are predicting, as well as allowing, Coca-Cola Brazil to change their future!
Taj pharmaceuticals healthcare-biotech industry - the economic timesShantanu Singh
taj pharmaceuticals limited News and Updates from The Economictimes.com. Taj Pharmaceuticals Limited News and Updates Taj Pharma Latest Breaking News, Pictures, Videos, and Special Reports Taj Pharma Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Taj Pharma Blogs, Comments and Archive New taj pharmaceuticals limited News and Updates from The Economictimes.com. Taj Pharmaceuticals Limited News and Updates from The Economictimes.com.Taj Pharmaceuticals Limited News - The Economic Times Taj Pharmaceuticals Limited Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Taj Pharmaceuticals Limited Blogs Photos i Pictures: taj taj pharmaceuticals limited: Bomaby taj pharmaceuticals limited News - The Economic Times Pharmaceuticals - Healthcare/Biotech - Industry Abhishek Singh Taj Pharma - The Economic Times Abhishek Singh Taj Pharma Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Abhishek Singh Taj Pharma Blogs taj pharmaceuticals limited industry taj pharmaceutical company taj pharma director Mumbai taj pharmaceutical companies taj pharmaceutical manufacturer taj pharmaceutical products taj pharmaceutical exporter manufacturers of taj pharma Mumbai taj pharma promotors taj pharmaceutical Mumbai taj pharma director taj pharma ceo taj pharma reviews taj pharma news taj pharma Abhishek singh Taj pharmaceuticals chemicals Api Agro Products taj pharmaceutical manufacturer india manufacturer of taj pharmaceuticals taj pharmaceutical injection taj pharmaceutical injections taj pharmaceuticals generics manufacturer india
StayinFront Leadership Perspective Roundtable Interview with Michael Del PrioreStayinFront
Michael Del Prior as Senior VP and CIO at Catalent Pharma Solutions shares his thoughts on the similarities and some of the key differences in terms of technology goals in the life sciences and consumer goods industries as a part of StayinFront’s Leadership Perspectives Series. He also talks about some of the technology drivers and disruptors in the same field.
Following years of growth and favourable market trends, the global life sciences industry now finds itself facing a ‘new normal’. By any measure it is still a stand-out performer globally, and a key strategic area for the EMEA region. However, markets are changing.
Life science companies must adopt new business models to achieve the following:
Counter slowing sales growth
Stem profitability challenges
Deliver patient outcomes that reflect higher consumer expectations
Position the industry for future success and innovation.
Making these adjustments successfully will come down to individual companies’ ability to find, engage and retain the right people. For the most part, the challenge is about talent and the ability of each organisation, regardless of location, to source it.
Here, we look at the top five issues facing the industry and how organisations in the region can respond.
The Irrationality of Measuring Brand Performance: Using Fame, Feeling & Fluen...System1 Group
Learning from behavioural science has taught us that humans think a lot less than we think they think. It demands the abandonment of the classical cognitive and persuasion-based marketing and communication models and instead, favors a simple, straightforward System 1 inspired brand-building approach governed by Fame, Feeling & Fluency:
•Fame: If a brand comes readily to mind, it's a good choice.
•Feeling: If a brand feels good, it's a good choice.
•Fluency: If a brand is recognizable, it's a good choice.
Tune in to hear Gabriel Aleixo (Managing Director - LatAm) and Alex Haubold (Research Associate) highlight how Coca-Cola deployed the highly predictive brand tracking model in Brazil to engage consumers in real time during the Rio 2016 Olympic Games. It will bring to life how Fame, Feeling & Fluency are predicting, as well as allowing, Coca-Cola Brazil to change their future!
Taj pharmaceuticals healthcare-biotech industry - the economic timesShantanu Singh
taj pharmaceuticals limited News and Updates from The Economictimes.com. Taj Pharmaceuticals Limited News and Updates Taj Pharma Latest Breaking News, Pictures, Videos, and Special Reports Taj Pharma Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Taj Pharma Blogs, Comments and Archive New taj pharmaceuticals limited News and Updates from The Economictimes.com. Taj Pharmaceuticals Limited News and Updates from The Economictimes.com.Taj Pharmaceuticals Limited News - The Economic Times Taj Pharmaceuticals Limited Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Taj Pharmaceuticals Limited Blogs Photos i Pictures: taj taj pharmaceuticals limited: Bomaby taj pharmaceuticals limited News - The Economic Times Pharmaceuticals - Healthcare/Biotech - Industry Abhishek Singh Taj Pharma - The Economic Times Abhishek Singh Taj Pharma Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. Abhishek Singh Taj Pharma Blogs taj pharmaceuticals limited industry taj pharmaceutical company taj pharma director Mumbai taj pharmaceutical companies taj pharmaceutical manufacturer taj pharmaceutical products taj pharmaceutical exporter manufacturers of taj pharma Mumbai taj pharma promotors taj pharmaceutical Mumbai taj pharma director taj pharma ceo taj pharma reviews taj pharma news taj pharma Abhishek singh Taj pharmaceuticals chemicals Api Agro Products taj pharmaceutical manufacturer india manufacturer of taj pharmaceuticals taj pharmaceutical injection taj pharmaceutical injections taj pharmaceuticals generics manufacturer india
StayinFront Leadership Perspective Roundtable Interview with Michael Del PrioreStayinFront
Michael Del Prior as Senior VP and CIO at Catalent Pharma Solutions shares his thoughts on the similarities and some of the key differences in terms of technology goals in the life sciences and consumer goods industries as a part of StayinFront’s Leadership Perspectives Series. He also talks about some of the technology drivers and disruptors in the same field.
Following years of growth and favourable market trends, the global life sciences industry now finds itself facing a ‘new normal’. By any measure it is still a stand-out performer globally, and a key strategic area for the EMEA region. However, markets are changing.
Life science companies must adopt new business models to achieve the following:
Counter slowing sales growth
Stem profitability challenges
Deliver patient outcomes that reflect higher consumer expectations
Position the industry for future success and innovation.
Making these adjustments successfully will come down to individual companies’ ability to find, engage and retain the right people. For the most part, the challenge is about talent and the ability of each organisation, regardless of location, to source it.
Here, we look at the top five issues facing the industry and how organisations in the region can respond.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
B2B payments are rapidly changing. Find out the 5 key questions you need to be asking yourself to be sure you are mastering B2B payments today. Learn more at www.BlueSnap.com.
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraAvirahi City Dholera
The Tata Group, a titan of Indian industry, is making waves with its advanced talks with Taiwanese chipmakers Powerchip Semiconductor Manufacturing Corporation (PSMC) and UMC Group. The goal? Establishing a cutting-edge semiconductor fabrication unit (fab) in Dholera, Gujarat. This isn’t just any project; it’s a potential game changer for India’s chipmaking aspirations and a boon for investors seeking promising residential projects in dholera sir.
Visit : https://www.avirahi.com/blog/tata-group-dials-taiwan-for-its-chipmaking-ambition-in-gujarats-dholera/
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
In the Adani-Hindenburg case, what is SEBI investigating.pptxAdani case
Adani SEBI investigation revealed that the latter had sought information from five foreign jurisdictions concerning the holdings of the firm’s foreign portfolio investors (FPIs) in relation to the alleged violations of the MPS Regulations. Nevertheless, the economic interest of the twelve FPIs based in tax haven jurisdictions still needs to be determined. The Adani Group firms classed these FPIs as public shareholders. According to Hindenburg, FPIs were used to get around regulatory standards.
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesHolger Mueller
Holger Mueller of Constellation Research shares his key takeaways from SAP's Sapphire confernece, held in Orlando, June 3rd till 5th 2024, in the Orange Convention Center.
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
3. 3
7,00 8,30 9,40 10,30 11,20 11,60 13,10
14,80
17,30
19,20
21,50
23,60
26,40
30,20
36,20
42,90
49,60
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Source: IMS Health.
Drivers Micro Momentum
Regional
Brands
Fragmented
Market
Sector
Formalization
Drivers Macro
Income
Growth
Population
Aging
Generic
Medicines
CAGR ‘08-12
Medicine: 13.5%
Generics: 24.9%
Branded: 11.1%
Sales performance in the Brazilian pharmaceutical market from 1996-2011 (R$ Billion)
Industry Performance
A Growth and Accelerating History
4. 4Source: BofAML Global Research, ANS
Market Drivers
Healthcare Plan Penetration
32 34 35 37 39 41 43 45 47 50 52 54 56 58 59 60 60 6018%
23%
27% 28%
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012e
2013e
2014e
2015e
2016e
2017e
2018e
2019e
2020e
Healthcare Plan Beneficiaries Penetration to total population (RHS)
35% 42% 50% 60% 66% 67% 69% 70% 72% 72% 73%
18%
21%
23%
24%
25% 24% 24% 23% 22% 22% 21%
47% 37% 27%
16% 10% 8% 7% 7% 6% 6% 6%
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
Group plans Individual Plans Not Informed
Healthcare plan beneficiaries are increasing at a 5% CAGR (2003 - 2013)
($ million)
Corporate plans already represent 73% share Decrease in unemployment drives the increase in group plans
($ million)
16 19 22 24 25 27 29 31 32
12,9% 12,4%
11,5%
9,9% 10,0%
9,3% 7,9% 8,1% 6,7%
2002 2003 2004 2005 2006 2007 2008 2009 2010
Number of group plans beneficiaries (lHS)
Unemployment (RHS)
5. 5
100 127 197
294
407
618
969
Health care spending per age group (100 basis)
27% 55%
49%
38%
52%
57%
Source: BofAML Global Research
The Brazilian population older than 60, the segment with the highest medication expenditure, is expected to increase
from 10% of the population in 2010 to 20% by 2030
Market Drivers
Brazil median age to match European countries by 2030
-20% -10% 0% 10% 20%
0 - 9
10 - 19
20 - 29
30 - 39
40 - 49
50 - 59
60 - 69
70 - 79
80+
Europe 2010 Brazil 2030
-20% -10% 0% 10% 20%
0 - 9
10 - 19
20 - 29
30 - 39
40 - 49
50 - 59
60 - 69
70 - 79
80+
Europe 2010 Brazil 2010
People over 65 years old spend more than 55% of total expenditures
23%
16%
17%
13%
8%
8%
7%
5%
29%
19%
19%
16%
12%
9%
10%
6%
Japan Europe U.K. U.S. China Global Brazil India
2010 2020
Percentage of population with more than 65 years to total population
6. 6
Note:
1. Total brand market sales estimates represent annualized sales; includes all expected generic launches in total brand numbers with key launches highlighted; assumes 6
months pediatric extension on all launches; forward looking information assumes no “at risk” launches ; 2. The timing of generic introductions and number of suppliers
can be impacted by a variety of factors, including legal challenges, regulatory issues and manufacturing capacity.
Sources: IMS Health; CVS research estimates.
Market Drivers
Generics continue to represent a significant opportunity in the coming years
20,4
35,5
11,2
16,8
13,3
2011 2012E 2013E 2014E 2015E
Total Brand Market Sales ( $ Bn)
Lipitor
Zyprexa
Levaquin
Concerta
Taxotere
Plavix
Singulair
Seroquel
Lexapro
Actos
Diovan
HCT
Eloxatin
Geodon
Tricor
Provigil
Cymbalta
Diovan
Niaspan
Nexium
Copaxone
Celebrex
Abilify
Namenda
Lovaza
Androgel
$ 97 Bn
in patents
overdue
7. 7Source: Itaú BBA Research.
Great opportunity for consolidation
Independents losing market-share for large drugstore chains
Market share by channel – number of stores, 2011 (%)
Top 5 retail chains market share
Medicine revenues, pharmaceutical market (%)
Market Drivers
Fragmented market. Opportunity to capture share of independent chains
62.0% 59.9% 55.1% 51.5% 49.1% 48.3% 47.9%
16.1% 17.0%
20.1% 22.6% 22.2% 22.7% 17.4%
5.5% 6.3% 6.5% 6.2% 6.5% 6.4%
5.5%
16.4% 16.8% 18.3% 19.7% 22.2% 22.6% 29.2%
2005 2006 2007 2008 2009 2010 2011
92.3% 91.7% 91.2% 90.8% 90.6% 89.3% 88.0%
5.1% 5.5% 5.8% 6.0% 6.0%
6.8%
6.6%
0.7% 0.8% 0.9% 1.0% 1.0% 1.2%
0.9%
1.9% 2.0% 2.1% 2.2% 2.4% 2.7% 4.5%
2005 2006 2007 2008 2009 2010 2011
29.2% 34.0%
66.0%
78.0%
70.8% 66.0%
34.0%
22.0%
Brazil Mexico USA Chile
Top 5 Others
Brazilian market is still very
fragmented
Market Share by channel – Income, 2011 (%)
Abrafarma Top 6 to10
Abrafarma Top 5
Independents
Supermarkets / Other chains
9. 9
Dream
Mission
People
• To be the best Drugstore Chain
in the country helping to
create a healthier world
• Provide health and well-being to our
customers
• Create Long-term partnerships with
our suppliers
• To have the best working climate to
develop our talents
• To be profitable to our Shareholders
• Attitude to go beyond
• Etics in all we do
• Proud to belong
• Focus on results
• Meritocracy to recognize our
talents
One Company, One Culture
11. 11Source: Brazil Pharma; Note: (1) Ranking by number of owned stores as of December 31, 2012 considering the four largest Drugstore chains in Brazil; (2) n/a: Other chains do not have
operations in the region
Drugstore ranking per Region
Number of Stores
1
4th
2nd
1st
Northeast
n/a
(2)
3rd
North
n/a
(2)
n/a
(2)
Southeast
n/a
(2)
Mid-west
n/a
(2)
South
n/a
(2)
Strong Local Knowledge
Number one in four out of five regions
12. 12
North 109
Northeast 244
Midwest 121
Southeast
South 207
REGIONS
Owned stores
10
1
108 20
15
21
11
198
7
75
116
1
9
237 Owned stores
116 Owned stores
121 Owned stores
369 Franchises
207 Owned stores
05 Distribution centers
Footprint 1,050 stores
89
86
Brazil Pharma footprint and clusters
Source: Brazil Pharma
National Footprint
The number one drugstore chain outside of the Southeast
2
13. 13
10.0%
12.4%
8.6%
16.2%
13.8% 15.1%
1Q11 2Q11 3Q11 1Q12 2Q12 3Q12
Number one in organic growth
Organic Growth (# owned stores)
Brazil Pharma Abrafarma
Branded GenericsHPC
Number one in sales mix
(3Q12)
Number one in regional growth
(CAGR07’-11’)
Strong growth potential
Number one in growth
Source: Brazil Pharma and IMS Health.
64.9%
28.5%
11.7%
37.1%
45.9%
17.0%
Number one in Same Store Sales
(3Q12)
333
90
95
109 54 681
2009 3Q12Openings
2011
Openings
9M12
Openings
2010
Openings
2009
1
1
1
1
15. 15
Footprint at and 12 months later the IPO
663 Points of sale
302 Owned Stores
361 Franchises
Platform @ IPO Actual Platform
207 Owned stores
369 Franchises
237 Owned stores
121 Owned stores
116 Owned stores
1,050 Points of sale
681 Owned stores
369 Franchises
89 Owned stores
60 Owned stores
153 Owned stores
361 Franchises
(1) Sant’Ana’s Distribution Center caught fire on December 2011. A new distribution center was inaugurated on November, 2012 ; (2) Includes 11 stores acquired from Estrela
Galdino on April , 2012 and added to Sant’Ana’s store count in June 30, 2012.Therefore they generated no revenues in 9M12.
1
(1Q11) (3Q12)
Distribution Center
Owned stores
Franchises
Increasing Footprint Since IPO
Strong delivery since the IPO…
16. 16
Increasing operational efficiency and stores productivity
Source : Brazil Pharma ; Notes: (1) Considers total stores and distribution centers employees ; (2) Considers total employees (store, distribution centers and administrative).
3.7 7.4
22.6 19.7
BRPH @ IPO (1Q11)
34,4 51.3
BRPH 3Q12
1.5 3.8
-13%
+100%
+153%
+49%
Store EBITDA / employee1
(R$ thousand)
# of store employees
per store
Sales per store / employee
(R$ thousand)
EBITDA / employee2
(R$ thousand)
Operational Performance Since IPO
...not only in growth, but also on the performance
3.8 3.6 -5%# of administrative + distribution
center employees per store
Stores Performance
Administrative Performance
17. Renato Lobo
Investor Relations Director
Otavio Lyra
Investor Relations Manager
Marina Sousa
Investor Relations Coordinator
Phone: +55 (11) 2117- 5299
E-mail: ri@brph.com.br
IR Website: ww.brph.com.br
IR CONTACT
Centro de Serviços Compartilhados - CSC, Brasília, DF